Twin Tree Management, LP Regeneron Pharmaceuticals, Inc. Transaction History

Twin Tree Management, LP

$50 Billion
Q3 2024

A detailed history of Twin Tree Management, LP transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Twin Tree Management, LP holds 14,400 shares of REGN stock, worth $9.73 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

14,400

Previous 17,500 17.71%

Holding current value

$9.73 Million

Previous $18.4 Million 17.7%

% of portfolio

0.03%

Previous 0.04%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$1024.09 - $1201.76 $9.1 Million - $10.7 Million	-8,887 Reduced 98.29%	155 $162,000
Q2 2024 Aug 13, 2024	SELL	$883.2 - $1071.19 $1.36 Million - $1.65 Million	-1,537 Reduced 14.53%	9,042 $9.5 Million
Q1 2024 May 09, 2024	SELL	$902.69 - $993.35 $3.07 Million - $3.38 Million	-3,399 Reduced 24.32%	10,579 $10.2 Million
Q4 2023 Feb 14, 2024	BUY	$775.18 - $881.7 $10.8 Million - $12.3 Million	13,978 New	13,978 $12.3 Million
Q2 2023 Aug 11, 2023	SELL	$700.03 - $830.35 $22.1 Million - $26.2 Million	-31,504 Reduced 92.56%	2,532 $1.82 Million
Q1 2023 May 10, 2023	BUY	$680.49 - $826.97 $10.4 Million - $12.6 Million	15,252 Added 81.2%	34,036 $28 Million
Q4 2022 Feb 13, 2023	SELL	$705.89 - $766.39 $13.3 Million - $14.4 Million	-18,850 Reduced 50.09%	18,784 $13.6 Million
Q3 2022 Nov 10, 2022	BUY	$573.97 - $724.32 $21.6 Million - $27.3 Million	37,634 New	37,634 $25.9 Million
Q1 2022 May 11, 2022	SELL	$595.12 - $698.43 $502,876 - $590,173	-845 Closed	0 $0
Q4 2021 Feb 10, 2022	SELL	$543.48 - $670.97 $15.6 Million - $19.2 Million	-28,632 Reduced 97.13%	845 $534,000
Q3 2021 Nov 12, 2021	BUY	$574.03 - $680.96 $812,252 - $963,558	1,415 Added 5.04%	29,477 $17.8 Million
Q2 2021 Aug 12, 2021	BUY	$472.8 - $558.54 $11 Million - $12.9 Million	23,178 Added 474.57%	28,062 $15.7 Million
Q1 2021 May 17, 2021	BUY	$446.73 - $548.2 $1.4 Million - $1.71 Million	3,127 Added 177.97%	4,884 $2.31 Million
Q3 2020 Nov 13, 2020	SELL	$544.75 - $658.21 $1.95 Million - $2.36 Million	-3,587 Reduced 67.12%	1,757 $984,000
Q2 2020 Aug 12, 2020	SELL	$493.32 - $643.92 $2.15 Million - $2.8 Million	-4,352 Reduced 44.88%	5,344 $3.33 Million
Q1 2020 May 13, 2020	BUY	$336.18 - $494.43 $3.26 Million - $4.79 Million	9,696 New	9,696 $4.73 Million
Q2 2019 Aug 12, 2019	SELL	$299.6 - $414.82 $1.49 Million - $2.06 Million	-4,967 Closed	0 $0
Q1 2019 May 10, 2019	SELL	$372.08 - $439.57 $6.74 Million - $7.96 Million	-18,115 Reduced 78.48%	4,967 $2.04 Million
Q2 2018 Aug 08, 2018	BUY	$284.6 - $344.99 $4.33 Million - $5.24 Million	15,203 Added 192.96%	23,082 $7.96 Million
Q4 2017 Feb 09, 2018	BUY	$358.63 - $469.95 $2.68 Million - $3.52 Million	7,482 Added 1884.63%	7,879 $2.96 Million
Q3 2017 Nov 13, 2017	BUY	$431.38 - $504.0 $171,257 - $200,088	397	397 $178,000

Others Institutions Holding REGN

# of Institutions

1,497

Shares Held

82.8M

Call Options Held

1.22M

Put Options Held

1.51M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $72.4B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Twin Tree Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Twin Tree Management, LP with notifications on news.

Account

Twin Tree Management, LP Regeneron Pharmaceuticals, Inc. Transaction History